4.7 Article

Matrix metalloproteinase targeted peptide vesicles for delivering anticancer drugs

Journal

CHEMICAL COMMUNICATIONS
Volume 54, Issue 67, Pages 9309-9312

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c8cc05687k

Keywords

-

Funding

  1. CSIR Mission Mode Project on Nano-biosensors and Microfluidics for Healthcare
  2. UGC, India
  3. ICMR, India
  4. CSIR, India

Ask authors/readers for more resources

A matrix metalloproteinase (MMP) targeted tetrapeptide vesicle has been designed and developed, which strongly binds at a MMP9 enzymatic site. Interestingly, it has a propensity to encapsulate and deliver the doxorubicin drug specifically to the cancer cell, induces superior apoptotic death, and inhibits the metastatic cancer cell migration and growth of multicellular 3D spheroids.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available